ATS 2019 Virtual Final Program

ATS 2019 • Dallas, TX CONFERENCE FACULTY AND PLANNERS DISCLOSURES CONFERENCE PLANNERS DISCLOSURES In accordance with the ACCME Standards for Commercial Support, and those of the ATS Policy on Management of Conflict of Interest in Official ATS Documents, Projects and Conferences, ATS Policy Governing Relationships Between the Tobacco Industry, ATS Members, and Non-Members Who Participate in ATS Activities, and ATS Policy on Professionalism and Ethical Conduct chairs, moderators, presenters and official planners of the International Conference are required to disclose to ATS any potential con- flicts of interest (COI) held by them or their spouse/life partner relevant to their presentation(s) or conference role, including all professional or other financial involvement with tobacco or e-cigarette entities, all relevant financial relationships with commercial interests, and all other relationships that could be perceived as influencing their participation. For the 2019 International Conference, this disclosure information for all individuals in control of content was requested and re- ceived by ATS in advance of the Conference, reviewed by appropriate ATS reviewers, and session chairs and others in positions of authority were instructed to manage (resolve) identified faculty conflicts according to procedures overseen by the ATS Ethics and Conflict of Interest Committee. To access the disclosures made by the faculty of the 2019 International Conference, please go to http://conference.thoracic.org/speakers The following members of the Education Committee have disclosed no financial relationships with commercial interests: The following members of the Education Committee have disclosed the following financial relationships with commercial interests: The following members of the International Conference Committee have disclosed no financial relationships with commercial interests: The following members of the International Conference Committee have disclosed the following financial relationships with commercial interests: Debra M. Boyer, MD, Chair Tisha S. Wang, MD, Vice Chair Shozab Ahmed, MBBS William G. Carlos, MD Josalyn L. Cho, MD Alison S. Clay, MD Jessica A. Cooksey, MD Basak Coruh, MD Daniel R. Crouch, MD, MS Charles Dela Cruz, MD, PhD Fei Jamie Dy, MD Garth Garrison, MD Jeffrey R. Goldstein Jane E. Gross, MD, PhD Robin L. Gross, MD Margaret M. Hayes, MD Amjad Horani, MD Shazia M. Jamil, MD Jon M. Keller, MD Hrishikesh S. Kulkarni, MD Melissa Lipford, MD Jakob I. McSparron, MD Paul E. Moore, MD Viswam S. Nair, MSCR, MD Scott S. Oh, DO Susan Pasnick, MD Hetal J. Patel, MD Samaan Rafeq, MD Jordan S. Rettig, MD Leopoldo N. Segal, MD Mary E. Strek, MD, ATSF Jess Mandel, MD, Chair Alison K. Bauer, PhD Sebastien Bonnet, PhD, MSc Vinicio De Jesus Perez, MD Charles Dela Cruz, MD, PhD Michelle Eakin, PhD Eddy Fan, MD, PhD Jill L. Guttormson, PhD, MS, RN Ilona Jaspers, PhD Meeta Prasad Kerlin, MD Leila Kheirandish-Gozal, MD, MS Sharon A. McGrath-Morrow, MD Sangeeta Mehta, MD Patrick Nana-Sinkam, MD Enid R. Neptune, MD Y.S. Prakash, MD, PhD Angela Rogers, MPH, MD Chun Seow, PhD Eric S. White, MD, MS: Chair Appointee: Boehringer-Ingelheim (Advisory Committee) Brian W. Carlin, MD : AstraZeneca (Advisory Committee); GlaxoSmithKline (Consultant); Monaghan Medical Corporation (Consultant, Speaker); Sunovion (Speaker) Harold R. Collard, MD: Genentech (Advisory Committee); Bayer, Boehringer Ingelheim, Global Blood Therapeutics, Parexel, Prometic, Toray, Unity (Consultant) Sharon D.M. Dell, MD: Novartis (Advisory Committee, Speaker), Trudell, Vertex (Advisory Committee) Bradley A. Edwards, PhD: Oventus Medical (Research Support) Maryl Kreider, MD, MSCE: Gilead, MedImmune, Sanofi (Research Support) Benjamin D. Medoff, MD: Regeneron (Advisory Committee) Anne Marie Russell, MScN: Roche (Advisory Committee, Consultant, Research Support, Speaker) Michael Steiner, MBBS, MD: Boehringer Ingelheim (Consultant, Other Transfers of Value, Speaker); GlaxoSmithKline (Advisory Committee); Nutricia (Consultant) Rachel Thomson, MBBS: Insmed (Advisory Committee, Consultant); Savara (Consultant) Anil Vachani, MD: Broncus Medical, Integrated Diagnostics, MagArray (Research Support); Onocyte (Advisory Committee, Research Support); Veracyte (Consultant); Aaronson Rapaport Feinstein & Deutsch, LLP, Bekman, Marder & Adkins, LLC, McAloon & Friedman, PC, McGuire Woods, LLC, Obermeyer Rebman Maxwell & Hippel LLP, United States Attorney’s Office, Wilcox & Savage, PC (Expert Testimony) Lisa R. Young, MD: Boehringer-Ingelheim (Advisory Committee) Caralee E. Caplan-Shaw, MD : AstraZeneca, Novartis (Research Support); Cohero Health (Consultant; Ownership or investment interests); Cook Incorporated (Food & Beverage Only; CME Speaker); Intuitive Surgical (Spouse-Speaker); Veran Medical Technologies (Spouse-Food & Beverage Only) Colleen L. Channick, MD: Actelion, Arena Pharmaceuticals, Bayer, Medtronic, Intuitive Surgical (Consultant) Tristan J. Huie, MD: Boehringer Ingelheim (Consultant, Research Support); Genentech (Consultant); Promedior (Research Support) Robert L. Owens, MD: ResMed (Other transfers of value) Mark D. Siegel, MD: McGraw Hill (Co-Editor-no financial compensation); UpToDate (Royalties, Author)